{"title":"More than half of Americans plan to get updated COVID shot","link":"https://arstechnica.com/?p=1969186","date":1695075424000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2023/09/GettyImages-1666317109-800x533.jpeg\" alt=\"A vial of the updated 2023-2024 formula of Pfizer's COVID-19 vaccine at a CVS Pharmacy in Eagle Rock, California, on September 14, 2023.\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2023/09/GettyImages-1666317109-scaled.jpeg\">Enlarge</a> <span>/</span> A vial of the updated 2023-2024 formula of Pfizer's COVID-19 vaccine at a CVS Pharmacy in Eagle Rock, California, on September 14, 2023. (credit: <a href=\"https://www.gettyimages.com/detail/news-photo/new-vaccine-comirnaty-by-pfizer-to-available-at-cvs-news-photo/1666317109?adppopup=true\">Getty | Irfan Khan</a>)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>Despite last year's abysmal fall booster campaign, more than half of US adults say they plan to get <a href=\"https://arstechnica.com/health/2023/09/updated-covid-boosters-get-green-light-from-fda-ahead-of-cdc-review/\">the latest COVID-19 vaccine</a>, which was <a href=\"https://arstechnica.com/health/2023/09/everyone-should-get-a-covid-booster-this-fall-cdc-says/\">greenlit by federal authorities last week</a>.</p>\n<p>According to polling by <a href=\"https://www.politico.com/news/2023/09/15/poll-covid-booster-democrats-00116123\">Politico</a> and <a href=\"https://pro.morningconsult.com/analysis/covid-19-booster-vaccine-poll\">Morning Consult</a>, 57 percent of registered voters said they would \"probably\" or \"definitely\" get the vaccine, which is a monovalent shot that targets the recent omicron subvariant, XBB.1.5. Specifically, 20 percent of voters said they would probably get the shot, while 37 percent said they definitely would.</p>\n<p>Collectively, that's nearly triple the actual uptake of <a href=\"https://arstechnica.com/science/2022/09/fda-authorizes-omicron-targeting-covid-boosters-from-moderna-and-pfizer/\">last year's updated vaccine, a bivalent shot</a> that targeted both the ancestral strain and the omicron subvariants BA.4/5. In total, <a href=\"https://covid.cdc.gov/covid-data-tracker/#vaccination-states-jurisdictions\">20.5 percent of people aged 18 or older received that shot</a>, according to the most recent data from the Centers for Disease Control and Prevention. Overall, 17 percent of the US population got the bivalent booster.</p></div><p><a href=\"https://arstechnica.com/?p=1969186#p3\">Read 6 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1969186&amp;comments=1\">Comments</a></p>","author":"Beth Mole","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"a65cc19b6d89f3ebc13850f43f502918d36f3cc9dbfba4943f00a6e5cb54abf2","category":"Tech"}